A man named Kiani, who is the boss of a company called Masimo, says that Apple Watches are not good at measuring blood oxygen levels. He thinks people should not use this feature on their watches because it might not work well and could be AIgerous if they trust it too much. The Apple Watch only checks blood oxygen two times a day, which is not enough according to Kiani. Also, the watch does not have permission from the government to say that it can measure blood oxygen for medical purposes. This feature was very important when Apple showed it off, but now they had to remove it in some countries because of a problem with another company called Masimo. Read from source...

1. The title of the article is misleading and sensationalist, as it implies that Apple Watch users are better off without blood oxygen monitoring feature, while in reality, it is a legal dispute between Masimo and Apple over patent infringement.
2. The use of quotations from Masimo CEO, Joe Kiani, is selective and cherry-picked to support the author's negative stance against Apple Watch blood oxygen monitoring feature, while ignoring other perspectives or evidence that might contradict his claims. For example, the article does not mention any independent studies or expert opinions that validate or challenge Kiani's assertion that pulse oximetry is only useful as a continuous monitor and that there could be a "dangerous desaturation" while users are asleep, which could go undetected since Apple Watches don't monitor it continuously.
3. The article also does not provide any data or statistics on how often or under what circumstances such AIgerous desaturation might occur, nor does it acknowledge that there might be other factors or conditions that influence blood oxygen levels besides sleep quality. Additionally, the article fails to mention that Apple Watch users can manually initiate a blood oxygen reading at any time through the Control Center or the Health app, which might mitigate some of the potential risks associated with periodic monitoring.
4. The article implies that Apple has not taken approval from the U.S. Food and Drug Administration (FDA) to certify its blood oxygen monitoring feature as a medical device, while omitting the fact that FDA clearance is not required for general wellness purposes, which is how Apple marketes its Blood Oxygen app. The article also does not mention that Masimo itself has been fined by the FDA in 2019 for misleading consumers about the accuracy and reliability of its pulse oximeters.